Temple University Biotech Spinout Acquired for $53M
Renovacor was spun out of Temple with the goal of developing drugs to combat genetic cardiological diseases.
Read the full article at: www.bizjournals.com
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
